Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2

Overview of attention for article published in Frontiers in immunology, August 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (68th percentile)
Good Attention Score compared to outputs of the same age and source (71st percentile)

Mentioned by

twitter: 4 X users

patent: 2 patents

Readers on

mendeley: 19 Mendeley

Summary X Patents

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 68,611 followers.

Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2 https://t.co/mGnNl5NehK

30 Aug 2021

Reply Repost Favourite

RT @FrontImmunol: New Research: Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2: The mutants resulted from…

30 Aug 2021

Reply Repost Favourite

Frontiers | Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2 | Immunology https://t.co/NTtDX5gtGn

30 Aug 2021

Reply Repost Favourite

New Research: Novel Monoclonal Antibodies and Recombined Antibodies Against Variant SARS-CoV-2: The mutants resulted from the ongoing SARS-CoV-2 epidemic have showed resistance to antibody neutralization and vaccine-induced immune response.… https://t.co/k

30 Aug 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.